Drug recall · March 26, 2014
Advil PM Caplets recall
Why: Subpotent Drug: This lot is being recalled because of out-of-specification test results for Diphenhydramine citrate.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Advil PM Caplets, (Ibuprofen, 200 mg /Diphenhydramine citrate, 38 mg) 120 count bottle, OTC, Pfizer, Madison, NJ 07940 USA. NDC 0573-0164-43
- Lots / codes
G85041
- Quantity
- 70,704 bottles
- Company
- Pfizer Us Pharmaceutical Group, New York, NY
- Distribution
- Nationwide
- Initiated
- February 26, 2014 · Voluntary: Firm initiated
- Classified
- March 18, 2014
- Reported
- March 26, 2014
- Ended
- July 10, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diphenhydramine / ibuprofen
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.